-
-
-
-
-
-
-
Raymond James Starts Aktis Oncology (AKTS) at Strong Buy (correction)
-
-
-
-
-
-
-
Truist on Eli Lilly (LLY): 'We see near-term and longer-term areas for growth'
-
-
-
-
-
-
-
Lilly cuts Germany investment plan in half over healthcare reforms
-
-
-
-
-
-
-
Eli Lilly & Co. (LLY) to buy three vaccine firms for up to $4B - WSJ
-
-
-
-
-
-
-
Lilly to present oncology data at ASCO 2026 meeting
-
-
-
-
-
-
-
FDA Commissioner Marty Makary to step down - Politico
-
-
-
-
-
-
-
Goldman Sachs on Eli Lilly (LLY): 'see the stock weakness as an overreaction'
-
418,741 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

